64/120
2.7 / 5 stars
All 120 Win/Lose results shown below
CORT Roast Me summary
CORCEPT THERAPEUTICS INC (CORT). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinCORT / S&P 115.70% / 15.20% |
WinCORT / S&P 16.02% / 15.00% |
LoseCORT / S&P -62.50% / 50.40% |
| 2026-Q12/3 |
WinCORT / S&P 15.83% / -4.33% |
WinCORT / S&P 12.20% / 11.30% |
LoseCORT / S&P -69.57% / 27.70% |
| 2025-Q41/3 |
LoseCORT / S&P -58.13% / 2.65% |
WinCORT / S&P 12.79% / 9.00% |
LoseCORT / S&P -33.33% / 13.40% |
| 2025-Q32/3 |
WinCORT / S&P 13.23% / 8.12% |
WinCORT / S&P 17.92% / 4.61% |
LoseCORT / S&P -30.95% / 13.45% |
| 2025-Q21/3 |
LoseCORT / S&P -35.74% / 10.94% |
WinCORT / S&P 25.71% / 4.83% |
LoseCORT / S&P -0.88% / 10.63% |
| 2025-Q12/3 |
WinCORT / S&P 126.67% / -4.27% |
WinCORT / S&P 30.93% / 4.98% |
LoseCORT / S&P 8.49% / 10.57% |
| 2024-Q43/3 |
WinCORT / S&P 8.88% / 2.41% |
WinCORT / S&P 39.94% / 5.25% |
WinCORT / S&P 30.85% / 6.15% |
| 2024-Q33/3 |
WinCORT / S&P 42.44% / 5.89% |
WinCORT / S&P 39.67% / 5.89% |
WinCORT / S&P 55.56% / 6.11% |
| 2024-Q23/3 |
WinCORT / S&P 28.98% / 4.28% |
WinCORT / S&P 33.04% / 5.38% |
WinCORT / S&P 36.14% / 5.12% |
| 2024-Q12/3 |
LoseCORT / S&P -22.44% / 10.56% |
WinCORT / S&P 26.51% / 5.71% |
WinCORT / S&P 29.27% / 5.59% |
| 2023-Q43/3 |
WinCORT / S&P 19.19% / 11.69% |
WinCORT / S&P 20.04% / 6.81% |
WinCORT / S&P 8.05% / 7.78% |
| 2023-Q32/3 |
WinCORT / S&P 22.47% / -3.27% |
WinCORT / S&P 13.18% / 7.52% |
LoseCORT / S&P -19.00% / -5.03% |
| 2023-Q20/3 |
LoseCORT / S&P 2.72% / 8.74% |
LoseCORT / S&P 9.22% / 9.50% |
LoseCORT / S&P -11.70% / -8.57% |
| 2023-Q11/3 |
LoseCORT / S&P 6.65% / 7.50% |
LoseCORT / S&P 8.84% / 10.77% |
WinCORT / S&P -9.89% / -15.69% |
| 2022-Q41/3 |
LoseCORT / S&P -20.79% / 7.56% |
LoseCORT / S&P 9.80% / 11.88% |
WinCORT / S&P -2.25% / -17.99% |
| 2022-Q32/3 |
WinCORT / S&P 7.82% / -4.88% |
LoseCORT / S&P 12.68% / 13.47% |
WinCORT / S&P 20.48% / -1.41% |
| 2022-Q23/3 |
WinCORT / S&P 5.60% / -16.10% |
WinCORT / S&P 14.26% / 13.71% |
WinCORT / S&P 23.68% / 11.04% |
| 2022-Q11/3 |
WinCORT / S&P 13.74% / -4.60% |
LoseCORT / S&P 11.81% / 15.97% |
LoseCORT / S&P 16.67% / 42.23% |
| 2021-Q40/3 |
LoseCORT / S&P 0.61% / 11.03% |
LoseCORT / S&P 3.42% / 15.00% |
LoseCORT / S&P 4.71% / 96.40% |
| 2021-Q30/3 |
LoseCORT / S&P -10.55% / 0.58% |
LoseCORT / S&P -0.88% / 10.77% |
LoseCORT / S&P -6.74% / 69.42% |
| 2021-Q20/3 |
LoseCORT / S&P -7.52% / 8.55% |
LoseCORT / S&P -2.31% / 6.58% |
LoseCORT / S&P -19.15% / 51.81% |
| 2021-Q11/3 |
LoseCORT / S&P -9.06% / 6.17% |
WinCORT / S&P 1.54% / -1.06% |
LoseCORT / S&P -11.36% / 7.39% |
| 2020-Q43/3 |
WinCORT / S&P 50.26% / 12.15% |
WinCORT / S&P 15.46% / -3.72% |
WinCORT / S&P 10.39% / -33.42% |
| 2020-Q32/3 |
LoseCORT / S&P 3.51% / 8.93% |
WinCORT / S&P 24.74% / -2.04% |
WinCORT / S&P 23.61% / -27.10% |
| 2020-Q23/3 |
WinCORT / S&P 41.46% / 20.54% |
WinCORT / S&P 30.87% / -0.46% |
WinCORT / S&P 46.87% / -27.11% |
| 2020-Q13/3 |
WinCORT / S&P -1.74% / -19.60% |
WinCORT / S&P 29.60% / 3.47% |
WinCORT / S&P 44.26% / -14.75% |
| 2019-Q42/3 |
LoseCORT / S&P -14.43% / 9.07% |
WinCORT / S&P 21.99% / 5.36% |
WinCORT / S&P 28.33% / 2.99% |
| 2019-Q32/3 |
WinCORT / S&P 26.82% / 1.70% |
WinCORT / S&P 20.08% / 5.02% |
LoseCORT / S&P -40.50% / 0.21% |
| 2019-Q21/3 |
LoseCORT / S&P -5.03% / 4.30% |
WinCORT / S&P 24.23% / 6.64% |
LoseCORT / S&P -45.76% / 8.65% |
| 2019-Q11/3 |
LoseCORT / S&P -12.13% / 13.65% |
WinCORT / S&P 36.54% / 8.12% |
LoseCORT / S&P -46.49% / 14.29% |
| 2018-Q42/3 |
WinCORT / S&P -4.71% / -13.52% |
WinCORT / S&P 57.82% / 9.05% |
LoseCORT / S&P -42.31% / 18.23% |
| 2018-Q31/3 |
LoseCORT / S&P -10.81% / 7.71% |
LoseCORT / S&P CORT unavailable / 10.21% |
WinCORT / S&P 317.24% / 19.06% |
| 2018-Q21/3 |
LoseCORT / S&P -4.44% / 3.43% |
LoseCORT / S&P CORT unavailable / 9.03% |
WinCORT / S&P 490.00% / 14.46% |
| 2018-Q11/3 |
LoseCORT / S&P -8.91% / -0.76% |
LoseCORT / S&P CORT unavailable / 7.68% |
WinCORT / S&P 936.36% / 12.46% |
| 2017-Q42/3 |
LoseCORT / S&P -6.42% / 6.64% |
WinCORT / S&P 95.77% / 7.03% |
WinCORT / S&P 1385.71% / 13.82% |
| 2017-Q31/3 |
WinCORT / S&P 63.56% / 4.48% |
LoseCORT / S&P CORT unavailable / 5.68% |
LoseCORT / S&P CORT unavailable / 17.57% |
| 2017-Q21/3 |
WinCORT / S&P 7.66% / 3.09% |
LoseCORT / S&P CORT unavailable / 4.83% |
LoseCORT / S&P CORT unavailable / 17.74% |
| 2017-Q11/3 |
WinCORT / S&P 50.96% / 6.07% |
LoseCORT / S&P CORT unavailable / 3.67% |
LoseCORT / S&P CORT unavailable / 13.32% |
| 2016-Q41/3 |
WinCORT / S&P 11.69% / 3.82% |
LoseCORT / S&P CORT unavailable / 2.09% |
LoseCORT / S&P CORT unavailable / 7.05% |
| 2016-Q31/3 |
WinCORT / S&P 19.05% / 3.85% |
LoseCORT / S&P CORT unavailable / 0.20% |
LoseCORT / S&P CORT unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | CORT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 63.15% | 20.78% |
| Annualized return | 63.15% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | CORT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 425.41% | 83.14% |
| Annualized return | 39.35% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | CORT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 2026.18% | 319.30% |
| Annualized return | 35.76% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |